ATE141794T1 - Stimulierung von wundheilung mit 15-keto- prostaglandinverbindungen - Google Patents

Stimulierung von wundheilung mit 15-keto- prostaglandinverbindungen

Info

Publication number
ATE141794T1
ATE141794T1 AT92302016T AT92302016T ATE141794T1 AT E141794 T1 ATE141794 T1 AT E141794T1 AT 92302016 T AT92302016 T AT 92302016T AT 92302016 T AT92302016 T AT 92302016T AT E141794 T1 ATE141794 T1 AT E141794T1
Authority
AT
Austria
Prior art keywords
wound healing
stimulating wound
prostaglandin compounds
keto prostaglandin
keto
Prior art date
Application number
AT92302016T
Other languages
English (en)
Inventor
Ryuji Ueno
Original Assignee
R Tech Ueno Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=13554827&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE141794(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by R Tech Ueno Ltd filed Critical R Tech Ueno Ltd
Application granted granted Critical
Publication of ATE141794T1 publication Critical patent/ATE141794T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT92302016T 1991-03-14 1992-03-10 Stimulierung von wundheilung mit 15-keto- prostaglandinverbindungen ATE141794T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7470291 1991-03-14

Publications (1)

Publication Number Publication Date
ATE141794T1 true ATE141794T1 (de) 1996-09-15

Family

ID=13554827

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92302016T ATE141794T1 (de) 1991-03-14 1992-03-10 Stimulierung von wundheilung mit 15-keto- prostaglandinverbindungen

Country Status (12)

Country Link
US (1) US5252605A (de)
EP (1) EP0503887B1 (de)
JP (1) JP2515458B2 (de)
KR (1) KR100221370B1 (de)
AT (1) ATE141794T1 (de)
AU (1) AU648877B2 (de)
CA (1) CA2062653C (de)
DE (1) DE69213057T2 (de)
DK (1) DK0503887T3 (de)
ES (1) ES2093774T3 (de)
GR (1) GR3021117T3 (de)
NZ (1) NZ241940A (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69327432T2 (de) * 1992-02-07 2000-05-18 Kaken Pharma Co Ltd Heilmittel für wunden und hämorrhoiden
TW420611B (en) * 1995-03-10 2001-02-01 R Tech Ueno Ltd Pharmaceutical composition containing prostanoic acid compounds for the treatment of optic nerve disorder
DE69714698T2 (de) 1996-06-10 2002-12-05 Sucampo Ag Endothelin-antagonisten
US6197821B1 (en) * 1997-11-28 2001-03-06 R-Tech Ueno, Ltd. Endothelin antagonist
TWI225398B (en) * 1999-07-14 2004-12-21 R Tech Ueno Ltd Composition for treatment of external secretion disorders
WO2002094274A1 (en) * 2001-05-18 2002-11-28 Sucampo Ag Cathartic composition
TWI331920B (en) 2001-11-14 2010-10-21 Sucampo Ag Unit dosage form for relieving or treating constipation in human patients
US20050124699A1 (en) * 2002-07-02 2005-06-09 Wakamoto Pharmaceutical Co., Ltd. Drugs for treating or preventing disorders of corneal and/or conjunctival epithelial cells
EP1535617A1 (de) * 2002-07-02 2005-06-01 Wakamoto Pharmaceutical Co., Ltd. Mittel zur behandlung oder prävention von keratokonjunctivalen epithelzell-verletzungen
EP1608378A1 (de) 2003-04-02 2005-12-28 Nexmed (Holdings), Inc. Prostaglandin-zusammensetzungen und ihre verwendung zur behandlung von vasospasmus
TW201410248A (zh) * 2005-03-04 2014-03-16 Sucampo Ag 處理週邊血管疾患之方法及組成物
WO2007086541A2 (en) 2006-01-24 2007-08-02 R-Tech Ueno, Ltd. Pharmaceutical composition comprising a bi-cyclic compound and method for stabilizing the bi-cyclic compound
US20090082442A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched lubiprostone
US8871752B2 (en) * 2008-02-19 2014-10-28 Sucampo Ag Method for modulating stem cell growth
US8513441B2 (en) 2008-08-29 2013-08-20 Alphora Research Inc. Prostaglandin synthesis and intermediates for use therein
CA2639240A1 (en) * 2008-08-29 2010-02-28 Alphora Research Inc. Prostaglandin synthesis and intermediates for use therein
WO2010083597A1 (en) * 2009-01-22 2010-07-29 Apotex Pharmachem Inc. Methods of making lubiprostone and intermediates thereof
US8609729B2 (en) * 2009-04-15 2013-12-17 Sucampo Ag Method for treating macular degeneration
BR112013025744A2 (pt) 2011-04-07 2016-08-16 Nexmed Holdings Inc composicões para tratamento da doença de raynaud
WO2018065826A1 (en) * 2016-10-06 2018-04-12 Sucampo Ag Multilayer beads for pharmaceutical use

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2740953A1 (de) * 1977-09-12 1979-03-22 Thera Ges Fuer Patente Verwendung von prostaglandinen zur senkung des blutzuckerspiegels
EP0153858A3 (de) * 1984-02-29 1985-12-11 The Upjohn Company Therapeutische Anwendung von Protaglandinen
JPS60208917A (ja) * 1984-02-29 1985-10-21 ジ・アツプジヨン・カンパニー Ａｒｄｓおよび多器官不全治療、予防におけるプロスタグランジンの使用
CA1322749C (en) * 1987-01-28 1993-10-05 Ryuzo Ueno Prostaglandins of the d series, and tranquilizers and soporifics containing the same
US5166174A (en) * 1987-01-28 1992-11-24 K.K. Ueno Seiyaku Oyo Kenkyujo Prostaglandins E and anti-ulcers containing same
CA1323364C (en) * 1987-01-28 1993-10-19 Ryuzo Ueno Prostaglandins e and anti ulcer agents containing same
CA1324129C (en) * 1987-04-30 1993-11-09 Ryuzo Ueno Prostaglandins of the f series
DE3869471D1 (de) * 1987-05-15 1992-04-30 Ueno Seiyaku Oyo Kenkyujo Kk Fiebersteigende zusammensetzung.
ES2052735T3 (es) * 1987-09-18 1994-07-16 R Tech Ueno Ltd Un metodo para producir un agente hipotensor ocular.
ES2051862T3 (es) * 1987-10-02 1994-07-01 Ueno Seiyaku Oyo Kenkyujo Kk Un metodo para producir un medicamento que tiene un efecto catartico.
JP2597629B2 (ja) * 1988-02-26 1997-04-09 株式会社 上野製薬応用研究所 １３，１４−ジヒドロ−１５−ケトプロスタグランジン類の安定化
JP2597649B2 (ja) * 1988-05-11 1997-04-09 株式会社上野製薬応用研究所 気管・気管支拡張剤
AU619543B2 (en) * 1988-05-11 1992-01-30 Sucampo Ag Use of 15-ketoprostaglandin e or f compounds for uterine contraction
DE68906193T2 (de) * 1988-05-23 1993-08-05 Ueno Seiyaku Oyo Kenkyujo Kk Hypersphyxia verursachende zusammensetzung.
JP2579193B2 (ja) * 1988-07-19 1997-02-05 小野薬品工業株式会社 １６，１６−ジフルオロ−１５−オキソ−１５−デオキシｐｇｅ誘導体

Also Published As

Publication number Publication date
US5252605A (en) 1993-10-12
DK0503887T3 (da) 1996-09-16
EP0503887A3 (en) 1993-01-13
JP2515458B2 (ja) 1996-07-10
DE69213057T2 (de) 1997-01-09
CA2062653A1 (en) 1992-09-15
ES2093774T3 (es) 1997-01-01
EP0503887B1 (de) 1996-08-28
KR100221370B1 (ko) 1999-09-15
NZ241940A (en) 1997-07-27
CA2062653C (en) 2002-08-20
DE69213057D1 (de) 1996-10-02
GR3021117T3 (en) 1996-12-31
EP0503887A2 (de) 1992-09-16
AU648877B2 (en) 1994-05-05
AU1286192A (en) 1992-09-17
JPH0570354A (ja) 1993-03-23
KR920017655A (ko) 1992-10-21

Similar Documents

Publication Publication Date Title
ATE141794T1 (de) Stimulierung von wundheilung mit 15-keto- prostaglandinverbindungen
ATE169219T1 (de) Behandlung von katarakt mit 15-keto- prostaglandinderivaten
ATE69376T1 (de) Haarwuchsmittel.
DE69118978D1 (de) Behandlung von entzündlichen Erkrankungen mit 15-Ketoprostaglandinen
DE69130586D1 (de) Behandlung von Pankreaskrankheit mit 15-keto-Prostaglandin E-Derivaten
DE69024744D1 (de) Behandlung der hepatobilären Erkrankung mit 15-Ketoprostaglandin-Derivaten
DE69032000D1 (de) Behandlung kardialer Dysfunktion mit 15-Ketoprostaglandinderivaten
DE69023459D1 (de) Behandlung von pulmonarer Disfunktion mit 15-Keto-prostaglandin-Derivaten.
ES2019634B3 (es) Terapia con clorfeniramina.
ATE146964T1 (de) Behandlung von katarakt mit prostacyclinverbindungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee